Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-15

FDA Approved: FEBUXOSTAT — Original Application (Hikma Pharmaceuticals USA Inc)

View source ↗

Summary

FDA approved Hikma Pharmaceuticals USA Inc for a generic febuxostat via an original ANDA (ANDA205414). This approval expands access to urate-lowering therapy fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FEBUXOSTAT (Febuxostat)

Snippet

ORIG AP for FEBUXOSTAT (FEBUXOSTAT)